Today, with such a wide selection of gadolinium-based contrast agents available to choose from; imaging professionals must be aware of the chemical make-up when selecting a MR agent for a particular exam.
This CME/CE accredited webinar with Lawrence N. Tanenbaum, MD, FACR, provides a review of the currently available FDA-approved MR contrast agents and their safety profiles. Following Dr. Tanenbaum's presentation questions from the audience were addressed in a moderated Q&A session.
This program has been made possible through an unrestricted educational grant from GE Healthcare